newsfilter
← Latest News
Business Wire·

PharmaCyte Biotech Announces Encapsulation Material Does Not Alter Cellular DNA

PharmaCyte Biotech, Inc. (NASDAQ:PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced further results from a third test o